-Universitätsklinikder

[68] Jadad, A. R., Browman, G. P. (1995). The WHO analgesic ladder for
cancer pain management. Stepping up the quality of its evaluation. JAMA
274 (23), 1870–1873
[69] Jain, P. N., Chatterjee, A., Choudhary, A. H., Sareen, R. (2009).
Prevalence, Etiology, and Management of Neuropathic Pain in an Indian
Cancer Hospital. Journal of Pain and Palliative Care Pharmacotherapy 23
(2), 114–119
[70] Jarupongprapa, S., Ussavasodhi, P., Katchamart, W. (2013). Comparison
of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and
non-selective, non-steroidal anti-inflammatory drugs plus proton pump
inhibitors: a systematic review and meta-analysis. J. Gastroenterol. 48 (7),
830–838
[71] Jost, L., Roila, F., ESMO Guidelines Working Group. (2010). Management
of cancer pain: ESMO Clinical Practice Guidelines. Ann. Oncol. 21 (5),
257–260
[72] Kalso, E. (2010). CHANGE PAIN- The vicious Circle in chronic Pain
Treatment: balancing between efficacy and adverse effects. Gehalten auf
der International Change Pain Expert Summit, Rome, Italy, 1–21
[73] Karow, T., Lang- Roth, Ruth. (2010). Allgemeine und spezielle
Pharmakologie und Toxikologie. Thomas Karow Verlag, Pulheim 570–578,
595–625
[74] Kaufman, M., Singh, G., Das, S., Concha-Parra, R., Erber, J., Micames, C.,
Gress, F. (2010). Efficacy of endoscopic ultrasound-guided celiac plexus
block and celiac plexus neurolysis for managing abdominal pain associated
with chronic pancreatitis and pancreatic cancer. J. Clin. Gastroenterol. 44
(2), 127–134
[75] Kingery, W. S. (1997). A critical review of controlled clinical trials for
peripheral neuropathic pain and complex regional pain syndromes. Pain 73
(2), 123–139
[76] Klaschik, E., Nauck, F., Radbruch, L., Sabatowski, R. (2000). Palliative
Medicine – Definition and Principles. Der Gynäkologe 33 (10), 704–710
[77] Kloke, M., Weber, M., Hanekop, G.-G. (2002). Tumorschmerztherapie im
Zeichen der Evidenz-basierten Medizin. Der Onkologe 8 (1), 44–46
69